SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cyberonics (cybx) epilepsy therapy recommonded
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dennis who wrote (174)3/16/1998 4:21:00 PM
From: yehuda fruchter  Read Replies (1) of 471
 
As someone recently posted, though the lockup period for Saint Jude is coming up, who says they are going to sell. In fact, my prediction is that Saint Jude will buy the company outright. This would allow them to compete favorably with Medtronic's neurological unit. Understand that the value of Cyberonics lies not only in its new treatment of epilepsy, but, in the development of a totally new technology which could be applicable to a wide variety of neurological disorders.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News